GLP
8 compounds in this category
GLP-1 receptor agonists are a class of compounds originally developed for type 2 diabetes that have demonstrated significant effects on body weight and metabolic markers. This category includes both approved medications and investigational compounds in clinical trials.
Caution
These are prescription medications with significant physiological effects. Muscle loss is a documented concern during rapid weight loss. GI side effects during dose escalation are common. Medical supervision is essential.
Good to Know
Clinical trials use careful dose escalation protocols to minimize side effects. Protein intake and resistance training are studied countermeasures for lean mass preservation during GLP-1 mediated weight loss.